CDLX Earnings & Financial Statements
Cardlytics, Inc.
$1.97
-$0.31(-13.60%)
40
Overall
40
Value
36
Tech
44
Quality
Market Cap
$13.43M
Volume
191.75K
52W Range
$2.47 - $26.70
Target Price
$7.50
CDLX earnings and financial statements: Cardlytics, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
CDLX Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $233.27M | $278.30M | $309.20M | $298.54M | $267.12M |
| Cost of revenue | $128.66M | $157.40M | $178.83M | $185.91M | $163.78M |
| Operating income | -$101.82M | -$195.50M | -$135.67M | -$457.78M | -$122.60M |
| EBITDA | -$68.16M | -$155.88M | -$102.85M | -$417.38M | -$88.21M |
| Net income | -$103.49M | -$189.30M | -$134.70M | -$465.26M | -$128.56M |
| EPS (diluted) | $-1.95 | $-39.10 | $-36.90 | $-139.20 | $-39.90 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $285.64M | $392.71M | $574.14M | $691.24M | $1.26B |
| Total liabilities | $292.15M | $322.72M | $439.35M | $479.63M | $573.10M |
| Shareholders’ equity | -$6.51M | $69.99M | $134.80M | $211.60M | $690.70M |
| Cash and equivalents | $48.72M | $65.59M | $91.83M | $121.91M | $233.47M |
| Long-term debt | $213.71M | $173.76M | $263.89M | $230.35M | $191.20M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $9.29M | -$8.82M | -$185.0K | -$53.90M | -$38.52M |
| Capital expenditure | -$15.78M | -$19.30M | -$12.39M | -$13.49M | -$12.56M |
| Free cash flow | -$6.49M | -$28.12M | -$12.58M | -$67.39M | -$51.09M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CDLX | $1.97 | -13.6% | 191.75K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |